Page last updated: 2024-10-20

pyridoxamine and Uveomeningoencephalitic Syndrome

pyridoxamine has been researched along with Uveomeningoencephalitic Syndrome in 1 studies

Uveomeningoencephalitic Syndrome: A syndrome characterized by bilateral granulomatous UVEITIS with IRITIS and secondary GLAUCOMA, premature ALOPECIA, symmetrical VITILIGO, poliosis circumscripta (a strand of depigmented hair), HEARING DISORDERS, and meningeal signs (neck stiffness and headache). Examination of the cerebrospinal fluid reveals a pattern consistent with MENINGITIS, ASEPTIC. (Adams et al., Principles of Neurology, 6th ed, p748; Surv Ophthalmol 1995 Jan;39(4):265-292)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, Z1
Iwata, D1
Kitaichi, N1
Takeuchi, M1
Sato, M1
Endo, N1
Iwabuchi, K1
Ando, R1
Fukuhara, J1
Kinoshita, S1
Lennikov, A1
Kitamura, M1
Mizuuchi, K1
Kanda, A1
Noda, K1
Namba, K1
Yamagishi, S1
Ohno, S1
Ishida, S1

Other Studies

1 other study available for pyridoxamine and Uveomeningoencephalitic Syndrome

ArticleYear
Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde-derived advanced glycation end-product formation.
    Journal of leukocyte biology, 2014, Volume: 96, Issue:6

    Topics: Administration, Oral; Adult; Amino Acid Sequence; Animals; Autoimmune Diseases; Behcet Syndrome; Dis

2014